Examiner.com Reporting Google Blog of Harold Mandel
Monday, January 30, 2012
Erivedge is the first FDA-approved drug for metastatic basal cell carcinoma
Erivedge is the first FDA-approved drug for metastatic basal cell carcinoma
Newer Post
Older Post
Home
Links
Legal Notice
Mandel News Service